Delpor
San Francisco
About Delpor
Delpor, Inc. engages in developing and acquiring drug delivery technologies that enable the sustained or pattern specific release of proteins, peptides, and small molecules through a small non-mechanical subcutaneous implant. Its technologies include Prozor, which is used for the delivery of antipsychotics and other small molecule drugs from a non-mechanical implantable drug delivery device; NANOPOR, a non-mechanical implantable drug delivery device in which sustained release is provided by membrane architecture; and Delos PUMP, a self-contained and electro-osmotically driven implantable drug delivery device to deliver drugs in predetermined patterns. The company was incorporated in 2009 and is based in San Francisco, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $4.9M
- Last round: Series Unknown (Aug 2023)
- Website: delpor.com
- Phone: 4154806871
Industries & Categories
Biopharma, Biotechnology, Commercial
Social Profiles
Canonical: https://fsome.com/organization/delpor-50674 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.